Menu
Search
|

Menu

Close
X

Sun Pharmaceutical Industries Ltd SUN.BO (Bombay Stock Exchange)

561.70 INR
-27.85 (-4.72%)
As of Nov 13
chart
Previous Close 589.55
Open 594.90
Volume 793,515
3m Avg Volume 435,244
Today’s High 594.90
Today’s Low 556.05
52 Week High 678.80
52 Week Low 434.80
Shares Outstanding (mil) 2,399.32
Market Capitalization (mil) 1,414,402.00
Forward P/E 37.00
Dividend (Yield %) 2.00 ( 0.34 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.78 Mean rating from 36 analysts

KEY STATS

Revenue (mm, INR)
FY19
72,242
FY18
264,895
FY17
316,140
FY16
284,870
FY15
273,920
EPS (INR)
FY19
4.095
FY18
10.039
FY17
28.946
FY16
18.921
FY15
20.231
*Note: Units in Millions of Rupee
**Note: Units in Rupee

KEY RATIOS

Price to Earnings (TTM)
vs sector
37.00
28.86
Price to Sales (TTM)
vs sector
5.14
23.49
Price to Book (MRQ)
vs sector
--
3.93
Price to Cash Flow (TTM)
vs sector
24.08
20.30
Total Debt to Equity (MRQ)
vs sector
--
15.17
LT Debt to Equity (MRQ)
vs sector
--
11.36
Return on Investment (TTM)
vs sector
--
12.65
Return on Equity (TTM)
vs sector
--
14.38

EXECUTIVE LEADERSHIP

Israel Makov
Non-Executive Chairman of the Board, Since 2012
Salary: --
Bonus: --
C. Muralidharan
Chief Financial Officer, Since 2017
Salary: --
Bonus: --
Sunil Ajmera
Compliance Officer, Company Secretary, Since 2011
Salary: --
Bonus: --
Dilip Shanghvi
Managing Director, Executive Director, Since 2012
Salary: Rs27,990,000.00
Bonus: --
Sailesh Desai
Whole-time Director, Since 1999
Salary: Rs9,867,000.00
Bonus: Rs1,973,400.00

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Acme Plaza
Andheri Kurla Road, Andheri East
MUMBAI     400093

Phone: +9122.43244324

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New Zealand and other markets. The Company offers its products to therapy areas, such as cardiology, neuro-psychiatry, gastroenterology, anti-infective, diabetology and dermatology. The Company's products include AB PHYLLINE, ABZORB DUSTING POWDER, ACAMPROL, ACOSTIN 3 MIU, ACOSTIN FORTE and AB PHYLLINE SR 200. Its manufacturing units are situated in India, the United States and Brazil, among others. Its units produce generics, branded generics, specialty products, over-the-counter (OTC) products, anti-retroviral (ARVs) and APIs. They also produce intermediates in a range of dosage forms, including tablets, capsules, injectables, ointments, creams and liquids.

SPONSORED STORIES